NORTHERN TRUST CORP - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 28 filers reported holding VIVOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,697
-62.3%
29,6550.0%0.00%
Q2 2023$15,124
+49.5%
29,6550.0%0.00%
Q1 2023$10,115
-15.1%
29,6550.0%0.00%
Q4 2022$11,921
-37.3%
29,6550.0%0.00%
Q3 2022$19,000
-63.5%
29,655
-27.3%
0.00%
Q2 2022$52,000
-52.3%
40,7660.0%0.00%
Q1 2022$109,000
+19.8%
40,766
+0.4%
0.00%
Q4 2021$91,000
-45.2%
40,604
-1.0%
0.00%
Q3 2021$166,000
+191.2%
41,027
+257.3%
0.00%
Q2 2021$57,00011,4830.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 162,500$804,0000.46%
BARD ASSOCIATES INC 215,500$1,067,0000.35%
Millrace Asset Group, Inc. 93,993$465,0000.24%
Archon Capital Management LLC 215,000$1,064,0000.12%
Penn Capital Management Company, LLC 223,403$1,106,0000.11%
GRIFFIN ASSET MANAGEMENT, INC. 49,500$245,0000.03%
K2 PRINCIPAL FUND, L.P. 64,746$320,0000.03%
Walleye Capital LLC 150,000$743,0000.02%
WMS Partners, LLC 16,667$153,0000.02%
Avalon Investment & Advisory 189,739$939,0000.02%
View complete list of VIVOS THERAPEUTICS INC shareholders